To investigate the underlying molecular mechanisms of FTO and ALKBH5 in CRC progression, we conducted RNA sequencing (RNA-seq) and m6A-modified RNA immunoprecipitation sequencing (MeRIP-seq) in CRC cells with stable FTO over-expression, ALKBH5 over-expression, and control cells. This evidence concerns the gene ALKBH5 and colorectal carcinoma.